Skip to content

Asteres’ ScriptCenter OK’d for use in N.J.

Asteres Inc. has gained approval from the New Jersey Board of Pharmacy for its ScriptCenter automated pharmacy kiosk to be used for 24×7 prescription pickup in hospitals and health care facilities.

Table of Contents

SAN DIEGO — Asteres Inc. has gained approval from the New Jersey Board of Pharmacy for its ScriptCenter automated pharmacy kiosk to be used for 24×7 prescription pickup in hospitals and health care facilities.

The company said Tuesday that the New Jersey Board of Pharmacy has been closely monitoring the ScriptCenter pilot at Jersey Shore University Medical Center, a member of Meridian Health, in Neptune, N.J.

After presenting findings, the board voted unanimously to approve the usage of ScriptCenter for delivery of all prescriptions, even when the pharmacy is closed. Asteres noted that the approval allows for Meridian to expand the kiosk’s use to other sites within the state and additional hospitals to submit pilot requests.

According to Asteres, hospitals like JSUMC are installing ScriptCenter to provide a convenient prescription drop-off and pick-up service to hospital employees, especially those who work when the pharmacy is closed.

"We are so excited to have 24×7 prescription pickup in our suite of team member services," stated Robert Schenk, manager of ambulatory pharmacy services. "Now our third shift team members will have the same access to the hospital’s in-house pharmacy, and all team members can quickly drop off and pick up prescriptions at their convenience. ScriptCenter allows us to better service our team members and grow our pharmacy without having to increase our labor costs."

To use ScriptCenter, employees enroll to create a unique ID and PIN, and they order prescriptions as usual. The pharmacy fills the prescriptions and loads them into the ScriptCenter, and then the employees pick up and pay for prescriptions at the kiosk, at any time.

Comments

Latest

FMI: Private brands take hold

FMI: Private brands take hold

Perceptions around private brands have changed; they are no longer seen merely as generics or national brand equivalents, Doug Baker, vice president, industry relations at FMI, said in releasing the report, titled “The Power of Private Brands 2024.”